Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 875 of 1294 entries
View as:

Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00655200 Org: User:
Start: 02/29/08 End: 09/30/08 Due: 09/30/09

A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06685185 Org: User:
Start: 11/12/24 End: 07/24/25 Due: 07/24/26

Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00184561 Org: User:
Start: 07/31/05 End: 07/31/06 Due: 07/31/07

A Trial Investigating the Mechanism of Action of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biopsies in Subjects With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT02097264 Org: User:
Start: 09/30/14 End: 09/30/15 Due: 09/30/16

Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02453711 Org: User:
Start: 10/01/15 End: 04/12/17 Due: 04/12/18

Comparison of Two Formulations of Biphasic Insulin Aspart 70

Phase: N/A Priority: Normal
NCT ID: NCT01523041 Org: User:
Start: 11/03/99 End: 11/30/99 Due: 11/30/00

An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE)

Phase: N/A Priority: Normal
NCT ID: NCT01018238 Org: User:
Start: 11/30/09 End: 11/30/09 Due: 11/30/10

Pharmacodynamics and Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01497561 Org: User:
Start: 03/31/03 End: 06/30/03 Due: 06/30/04

A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity

Phase: N/A Priority: Normal
NCT ID: NCT04143945 Org: User:
Start: 10/28/19 End: 01/04/20 Due: 01/04/21

A Study Investigating the Safety and Performance of DV3395, a New Concept Device for the Delivery of Medicine.

Phase: N/A Priority: Normal
NCT ID: NCT05314283 Org: User:
Start: 03/28/22 End: 11/08/22 Due: 11/08/23

A Thorough QTc Evaluation of the Effect of Semaglutide on Cardiac Repolarisation in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02064348 Org: User:
Start: 02/26/14 End: 04/23/15 Due: 04/23/16

Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03268005 Org: User:
Start: 09/19/17 End: 01/29/19 Due: 01/29/20

First Human Dose Trial for a New Medication to Potentially Treat Liver Diseases

Phase: N/A Priority: Normal
NCT ID: NCT05599945 Org: User:
Start: 11/23/22 End: 08/28/25 Due: 08/28/26

A Trial Investigating the Concentration in the Blood of NN1250 in Children, Adolescents and Adults With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01030926 Org: User:
Start: 12/31/09 End: 05/31/10 Due: 05/31/11

Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01269606 Org: User:
Start: 01/31/11 End: 03/31/11 Due: 03/31/12

Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.

Phase: N/A Priority: Normal
NCT ID: NCT02970942 Org: User:
Start: 11/30/16 End: 03/19/20 Due: 03/19/21

A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investigating Single Dose Pharmacokinetics and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT02920398 Org: User:
Start: 10/04/16 End: 04/07/17 Due: 04/07/18

Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00660374 Org: User:
Start: 02/29/08 End: 03/31/09 Due: 03/31/10

Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03377699 Org: User:
Start: 11/22/17 End: 12/17/20 Due: 12/17/21

Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01720446 Org: User:
Start: 02/21/13 End: 03/15/16 Due: 03/15/17

Assessing Health-Related Quality of Life and Willingness to Pay for Weight Management in Asia-Pacific by Gender

Phase: N/A Priority: Normal
NCT ID: NCT06260696 Org: User:
Start: 08/10/23 End: 10/05/23 Due: 10/05/24

A Research Study Investigating Mim8 in People With Haemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT04204408 Org: User:
Start: 01/10/20 End: 10/06/23 Due: 10/06/24

Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00698802 Org: User:
Start: 06/30/08 End: 03/31/09 Due: 03/31/10

A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia

Phase: N/A Priority: Normal
NCT ID: NCT06859073 Org: User:
Start: 11/13/24 End: 07/07/26 Due: 07/07/27

A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin

Phase: N/A Priority: Normal
NCT ID: NCT01570751 Org: User:
Start: 04/30/12 End: 01/31/14 Due: 01/31/15